fda glp-1 warning letters september 2025 news Patients taking an experimental oral drug lost significant weight and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other FDA Issues Warning Letters to

While GLP-1 medications were designed to regulate blood sugar, they also appear to have anti-inflammatory and pain-modulating effects

Off-label prescribing can also trigger concerns around fraud, waste, and abuse, particularly in regulated markets

5 Not all prescriptions can be filled in a 90-day supply and may need to be filled at select retail pharmacies or via home delivery

By multiple, we mean at least three, but many patients may have five or more (Laiteerapong N, Iveniuk J, John PM, Laumann EO, Huang ES

Our program includes: Comprehensive medical consultation Individualized treatment planning Laboratory review when clinically appropriate Ongoing monitoring and follow-up Medication is prescribed only when deemed appropriate by a licensed healthcare provider